Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Creese

Showing results (91-100 of 142) with videos related to

Pageof 15
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brainA B Norman, J H Eubanks, I Creese
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugsI Creese, D R Burt, S H Snyder
Federation Proceedings|October 1, 1984
Agonist interactions with dopamine receptors: focus on radioligand-binding studiesI Creese, D R Sibley, S E Leff
Molecular Pharmacology|March 1, 1983
Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding stateD R Sibley, L C Mahan, I Creese
Life Sciences|August 16, 1982
Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptorsD R Sibley, S E Leff, I Creese
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976
The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonistsA P Feinberg, I Creese, S H Snyder
Advances in Biochemical Psychopharmacology|January 1, 1979
Molecular actions of opiates: historical overview and new findings on opiate receptor interactions with enkephalins and guanyl nucleotidesS H Snyder, S R Childers, I Creese
Federation Proceedings|February 1, 1981
Dopamine receptors: subtypes, localization and regulationI Creese, D R Sibley, S Leff, et al.
Life Sciences|November 16, 1981
Ascorbic acid enables reversible dopamine receptor 3H-agonist bindingS Leff, D R Sibley, M Hamblin, et al.
Molecular Pharmacology|January 1, 1987
Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitroE J Hess, G Battaglia, A B Norman, et al.
Pageof 15

Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1989
Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brainA B Norman, J H Eubanks, I Creese
The Journal of Neuropsychiatry and Clinical Neurosciences|January 1, 1996
Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugsI Creese, D R Burt, S H Snyder
Federation Proceedings|October 1, 1984
Agonist interactions with dopamine receptors: focus on radioligand-binding studiesI Creese, D R Sibley, S E Leff
Molecular Pharmacology|March 1, 1983
Dopamine receptor binding on intact cells. Absence of a high-affinity agonist-receptor binding stateD R Sibley, L C Mahan, I Creese
Life Sciences|August 16, 1982
Interactions of novel dopaminergic ligands with D-1 and D-2 dopamine receptorsD R Sibley, S E Leff, I Creese
Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976
The opiate receptor: a model explaining structure-activity relationships of opiate agonists and antagonistsA P Feinberg, I Creese, S H Snyder
Advances in Biochemical Psychopharmacology|January 1, 1979
Molecular actions of opiates: historical overview and new findings on opiate receptor interactions with enkephalins and guanyl nucleotidesS H Snyder, S R Childers, I Creese
Federation Proceedings|February 1, 1981
Dopamine receptors: subtypes, localization and regulationI Creese, D R Sibley, S Leff, et al.
Life Sciences|November 16, 1981
Ascorbic acid enables reversible dopamine receptor 3H-agonist bindingS Leff, D R Sibley, M Hamblin, et al.
Molecular Pharmacology|January 1, 1987
Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitroE J Hess, G Battaglia, A B Norman, et al.
Pageof 15